Show simple item record

dc.contributor.authorWong, Chun Yuen
dc.contributor.authorAl-Salami, Hani
dc.contributor.authorDass, Crispin
dc.date.accessioned2018-12-13T09:11:46Z
dc.date.available2018-12-13T09:11:46Z
dc.date.created2018-12-12T02:46:29Z
dc.date.issued2018
dc.identifier.citationWong, C.Y. and Al-Salami, H. and Dass, C. 2018. Recent advancements in oral administration of insulin-loaded liposomal drug delivery systems for diabetes mellitus. International Journal of Pharmaceutics. 549 (1-2): pp. 201-217.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/71928
dc.identifier.doi10.1016/j.ijpharm.2018.07.041
dc.description.abstract

© 2018 Elsevier B.V. Diabetes is a chronic medical condition, which is characterised by high blood sugar level. Exogenous insulin is commonly administered subcutaneously for the management of diabetes. However, daily injections of insulin could result in poor patient compliance and various side-effects. Although oral administration offers benefits, insulin is vulnerable to enzymatic degradation, chemical instability and poor gastrointestinal absorption. There is an absence of reviews on insulin-loaded liposomal drug carriers, despite that fact that liposomes have gained considerable attention recently for oral delivery of insulin. They demonstrate favourable characteristics, such as versatility, biocompatibility, protective effect against enzymatic degradation, and cell-specific targeting. In this review, we will explore the status quo for oral delivery of insulin-loaded liposomal formulations, followed by discussing the state of art of these vesicles. This review will provide a detailed overview on insulin-loaded conventional liposomes, and 7 types of current novel formulations. Lastly, the future direction for oral bioavailability enhancement and development of such nanoscale drug delivery systems will be discussed. Further optimisation in the drug entrapment efficiency and gastrointestinal absorption will be required to develop a clinically successful oral liposome-insulin formulation.

dc.publisherElsevier BV
dc.titleRecent advancements in oral administration of insulin-loaded liposomal drug delivery systems for diabetes mellitus
dc.typeJournal Article
dcterms.source.volume549
dcterms.source.number1-2
dcterms.source.startPage201
dcterms.source.endPage217
dcterms.source.issn0378-5173
dcterms.source.titleInternational Journal of Pharmaceutics
curtin.departmentSchool of Nursing, Midwifery and Paramedicine
curtin.accessStatusFulltext not available


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record